Literature DB >> 14208436

INTACT TUMOR CELLS IN IRRADIATED TISSUE.

H D SUIT, H S GALLAGER.   

Abstract

Keywords:  EXPERIMENTAL LAB STUDY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM RADIOTHERAPY; PATHOLOGY

Mesh：

Year:  1964        PMID： 14208436

Source DB:  PubMed          Journal:  Arch Pathol        ISSN： 0363-0153


× No keyword cloud information.
  9 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Sungwon Kim; Kyunghwa Han; Nieun Seo; Hye Jin Kim; Myeong-Jin Kim; Woong Sub Koom; Joong Bae Ahn; Joon Seok Lim
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

3.  Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.

Authors:  Xiaojie Wang; Zhifang Zheng; Heyuan Zhu; Qian Yu; Shenghui Huang; Xingrong Lu; Ying Huang; Pan Chi
Journal:  Int J Colorectal Dis       Date:  2021-01-04       Impact factor: 2.571

Review 4.  Current approaches and recent developments in the management of head and neck paragangliomas.

Authors:  David Taïeb; Alexandre Kaliski; Carsten C Boedeker; Victoria Martucci; Tito Fojo; John R Adler; Karel Pacak
Journal:  Endocr Rev       Date:  2014-07-17       Impact factor: 19.871

5.  Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy.

Authors:  Jae Young Kwak; Chan Wook Kim; Seok-Byung Lim; Chang Sik Yu; Tae Won Kim; Jong Hoon Kim; Se Jin Jang; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2012-08-10       Impact factor: 3.452

6.  Effect of interval between neoadjuvant chemoradiotherapy and surgery on disease recurrence and survival in rectal cancer: long-term results of a randomized clinical trial.

Authors:  Erhan Akgun; Cemil Caliskan; Osman Bozbiyik; Tayfun Yoldas; Basak Doganavsargil; Serdar Ozkok; Timur Kose; Bulent Karabulut; Nevra Elmas; Omer Ozutemiz
Journal:  BJS Open       Date:  2022-09-02

7.  Short Course Radiation in the Treatment of Localized Rectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Cui Chen; Peng Sun; Jian Rong; Hui-Wen Weng; Qiang-sheng Dai; Sheng Ye
Journal:  Sci Rep       Date:  2015-06-09       Impact factor: 4.379

8.  Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial.

Authors:  Yi-Kan Cheng; Qi-Yuan Qin; Xiao-Yan Huang; Ping Lan; Lei Wang; Xiang Gao; Teng-Hui Ma
Journal:  Cancer Med       Date:  2019-12-12       Impact factor: 4.452

9.  Short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma.

Authors:  Ali Shamseddine; Youssef H Zeidan; Malek Kreidieh; Ibrahim Khalifeh; Rim Turfa; Joseph Kattan; Deborah Mukherji; Sally Temraz; Kholoud Alqasem; Rula Amarin; Tala Al Awabdeh; Samer Deeba; Faek Jamali; Issa Mohamad; Mousa Elkhaldi; Faiez Daoud; Mahmoud Al Masri; Ali Dabous; Ahmad Hushki; Omar Jaber; Clement Khoury; Ziad El Husseini; Maya Charafeddine; Monita Al Darazi; Fady Geara
Journal:  BMC Cancer       Date:  2020-09-01       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.